Catherine C. Turkel

Chief Development Officer, Eledon Pharmaceuticals, Inc.

Companies

Lexaria Bioscience Corp.Board member Sep 6, 2022 to Aug 13, 2024¹
Eledon Pharmaceuticals, Inc.President Nov 6, 2017 to Mar 20, 2020²
Eledon Pharmaceuticals, Inc.Chief Development Officer May 11, 2017 to May 26, 2017³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Lexaria Bioscience Corp. LEXX1,500 shares⁴$3.9K at $2.62Aug 13, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Aug 12, 2024Bought 1,600 shares at $3.13 of Lexaria Bioscience Corp.⁴
Feb 9, 2023Bought 1,500 shares at $2.84 of Lexaria Bioscience Corp.⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARLexaria Bioscience Corp., Board member
2
SEC EDGAREledon Pharmaceuticals, Inc., President
3
SEC EDGAREledon Pharmaceuticals, Inc., Chief Development Officer
4
SEC EDGARLexaria Bioscience Corp. shares after the filing of Aug 13, 2024
5
SEC EDGARForm 4 filed Feb 27, 2023